BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Virk RK, Abro S, de Ubago JMM, Pambuccian SE, Quek ML, Wojcik EM, Mehrotra S, Chatt GU, Barkan GA. The value of the UroVysion® FISH assay in the risk-stratification of patients with “atypical urothelial cells” in urinary cytology specimens: The Value of the UroVysion® FISH Assay. Diagn Cytopathol 2017;45:481-500. [DOI: 10.1002/dc.23686] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 3.6] [Reference Citation Analysis]
Number Citing Articles
1 Glass R, Rosca O, Raab S, Szabelska J, Chau K, Sheikh‐fayyaz S, Cocker R. Applying the Paris system for reporting urine cytology to challenging cytology cases. Diagn Cytopathol 2019. [DOI: 10.1002/dc.24166] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
2 Rodriguez Pena MDC, Springer SU, Taheri D, Li L, Tregnago AC, Eich M, Eltoum IA, Vandenbussche CJ, Papadopoulos N, Kinzler KW, Vogelstein B, Netto GJ. Performance of novel non-invasive urine assay UroSEEK in cohorts of equivocal urine cytology. Virchows Arch 2020;476:423-9. [DOI: 10.1007/s00428-019-02654-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
3 Cowan ML, Vandenbussche CJ. The Paris System for Reporting Urinary Cytology: early review of the literature reveals successes and rare shortcomings. Journal of the American Society of Cytopathology 2018;7:185-94. [DOI: 10.1016/j.jasc.2018.04.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
4 Wang YH, Hang JF, Wen CH, Liao KC, Lee WY, Lai CR. Diagnostic Agreement for High-Grade Urothelial Cell Carcinoma in Atypical Urine Cytology: A Nationwide Survey Reveals a Tendency for Overestimation in Specimens with an N/C Ratio Approaching 0.5. Cancers (Basel) 2020;12:E272. [PMID: 31979119 DOI: 10.3390/cancers12020272] [Reference Citation Analysis]
5 Sassa N, Iwata H, Kato M, Murase Y, Seko S, Nishikimi T, Hattori R, Gotoh M, Tsuzuki T. Diagnostic Utility of UroVysion Combined With Conventional Urinary Cytology for Urothelial Carcinoma of the Upper Urinary Tract. Am J Clin Pathol 2019;151:469-78. [PMID: 30668617 DOI: 10.1093/ajcp/aqy170] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
6 Piao XM, Byun YJ, Kim WJ, Kim J. Unmasking molecular profiles of bladder cancer. Investig Clin Urol 2018;59:72-82. [PMID: 29520382 DOI: 10.4111/icu.2018.59.2.72] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
7 Rosolen DCB, Faria DK, Faria CS, Antonangelo L. Performance of the UroVysion® FISH assay for the diagnosis of malignant effusions using two cutoff strategies. Cancer Med 2018;7:1967-77. [PMID: 29577646 DOI: 10.1002/cam4.1442] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Nikas IP, Seide S, Proctor T, Kleinaki Z, Kleinaki M, Reynolds JP. The Paris System for Reporting Urinary Cytology: A Meta-Analysis. JPM 2022;12:170. [DOI: 10.3390/jpm12020170] [Reference Citation Analysis]
9 McHale T, Ohori NP, Cieply KM, Sherer C, Bastacky SI. Comparison of urinary cytology and fluorescence in situ hybridization in the detection of urothelial neoplasia: An analysis of discordant results. Diagn Cytopathol 2019;47:282-8. [PMID: 30417563 DOI: 10.1002/dc.24108] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Wilson BL, Russell D, Evans SK, Agrawal T. Cell blocks in urine cytopathology: do they add value to the diagnosis? A pilot study. J Am Soc Cytopathol 2021;10:47-55. [PMID: 33039333 DOI: 10.1016/j.jasc.2020.08.003] [Reference Citation Analysis]
11 Crocetto F, Barone B, Ferro M, Busetto GM, La Civita E, Buonerba C, Di Lorenzo G, Terracciano D, Schalken JA. Liquid biopsy in bladder cancer: State of the art and future perspectives. Crit Rev Oncol Hematol 2022;170:103577. [PMID: 34999017 DOI: 10.1016/j.critrevonc.2022.103577] [Reference Citation Analysis]
12 Ren C, Wang X, Yang C, Li S, Liu S, Cao H. Investigation of Atyp.C using UF-5000 flow cytometer in patients with a suspected diagnosis of urothelial carcinoma: a single-center study. Diagn Pathol 2020;15:77. [PMID: 32586345 DOI: 10.1186/s13000-020-00993-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Sciarra A, Di Lascio G, Del Giudice F, Leoncini PP, Salciccia S, Gentilucci A, Porreca A, Chung BI, Di Pierro G, Busetto GM, De Berardinis E, Maggi M. Comparison of the clinical usefulness of different urinary tests for the initial detection of bladder cancer: a systematic review. Curr Urol 2021;15:22-32. [PMID: 34084118 DOI: 10.1097/CU9.0000000000000012] [Cited by in F6Publishing: 1] [Reference Citation Analysis]